COVID-related Stress and Substance Use: Examining the Role of Sleep Disturbance

Overview

Journal Cogn Behav Ther

Specialties Pharmacology
Social Sciences

Date 2022 Jun 28

PMID 35762877

Authors

Anka A Vujanovic

Brooke Y Kauffman

Maya Zegel

Michael J Zvolensky

Affiliations

Soon will be listed here.

Abstract

The current investigation employed a cross-sectional design to evaluate the associations of COVID-19 stress, sleep disturbance, and substance use among a national sample of 143 adults (57.3% male, = 38.5 years, = 11.28), surveyed at a single time-point using Amazon's MTurk platform. We hypothesized that COVID-19-related stress would be indirectly related to substance use outcomes (i.e. number of substance classes used daily, number of alcoholic drinks per occasion, substance use coping motives; but not substance use enhancement motives) through sleep disturbance severity. As expected, results indicated that the models examining indirect effects were statistically significant for number of substance classes used daily and substance use coping motives. However, there was no evidence that sleep disturbance explained the relation between COVID-19-related stress and number of alcoholic drinks per occasion or substance use enhancement motives. These findings underscore the importance of sleep disturbance in efforts to better understand how COVID-19-related stress is associated with certain types of substance use behavior.

References

Ramalho R, Adiukwu F, Gashi Bytyci D, El Hayek S, Gonzalez-Diaz J, Larnaout A . Telepsychiatry and healthcare access inequities during the COVID-19 pandemic. Asian J Psychiatr. 2020; 53:102234. PMC: 7296313. DOI: 10.1016/j.ajp.2020.102234. View

Biolcati R, Passini S . Development of the Substance Use Motives Measure (SUMM): A comprehensive eight-factor model for alcohol/drugs consumption. Addict Behav Rep. 2019; 10:100199. PMC: 6731325. DOI: 10.1016/j.abrep.2019.100199. View

Hyun S, Hahm H, Wong G, Zhang E, Liu C . Psychological correlates of poor sleep quality among U.S. young adults during the COVID-19 pandemic. Sleep Med. 2021; 78:51-56. PMC: 7887075. DOI: 10.1016/j.sleep.2020.12.009. View

Baker T, Piper M, McCarthy D, Majeskie M, Fiore M . Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004; 111(1):33-51. DOI: 10.1037/0033-295X.111.1.33. View

MacMillan T, Corrigan M, Coffey K, Tronnier C, Wang D, Krase K . Exploring Factors Associated with Alcohol and/or Substance Use During the COVID-19 Pandemic. Int J Ment Health Addict. 2021; 20(3):1814-1823. PMC: 7837073. DOI: 10.1007/s11469-020-00482-y. View

Lagisetty P, Maust D, Heisler M, Bohnert A . Physical and Mental Health Comorbidities Associated With Primary Care Visits For Substance Use Disorders. J Addict Med. 2017; 11(2):161-162. PMC: 5356485. DOI: 10.1097/ADM.0000000000000280. View

Lai H, Cleary M, Sitharthan T, Hunt G . Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015; 154:1-13. DOI: 10.1016/j.drugalcdep.2015.05.031. View

Pfefferbaum B, North C . Mental Health and the Covid-19 Pandemic. N Engl J Med. 2020; 383(6):510-512. DOI: 10.1056/NEJMp2008017. View

Cheung M . Comparison of methods for constructing confidence intervals of standardized indirect effects. Behav Res Methods. 2009; 41(2):425-38. DOI: 10.3758/BRM.41.2.425. View

10.

Ko W, Rolain J, Lee N, Chen P, Huang C, Lee P . Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020; 55(4):105933. PMC: 7135364. DOI: 10.1016/j.ijantimicag.2020.105933. View

11.

McKay D, Asmundson G . COVID-19 stress and substance use: Current issues and future preparations. J Anxiety Disord. 2020; 74:102274. PMC: 7371588. DOI: 10.1016/j.janxdis.2020.102274. View

12.

Ettman C, Abdalla S, Cohen G, Sampson L, Vivier P, Galea S . Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2020; 3(9):e2019686. PMC: 7489837. DOI: 10.1001/jamanetworkopen.2020.19686. View

13.

Preacher K, Hayes A . Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008; 40(3):879-91. DOI: 10.3758/brm.40.3.879. View

14.

Carey M, Al-Zaiti S, Dean G, Sessanna L, Finnell D . Sleep problems, depression, substance use, social bonding, and quality of life in professional firefighters. J Occup Environ Med. 2011; 53(8):928-33. PMC: 3486736. DOI: 10.1097/JOM.0b013e318225898f. View

15.

Wright Jr K, Linton S, Withrow D, Casiraghi L, Lanza S, de la Iglesia H . Sleep in university students prior to and during COVID-19 Stay-at-Home orders. Curr Biol. 2020; 30(14):R797-R798. PMC: 7284257. DOI: 10.1016/j.cub.2020.06.022. View

16.

Rogers A, Shepherd J, Garey L, Zvolensky M . Psychological factors associated with substance use initiation during the COVID-19 pandemic. Psychiatry Res. 2020; 293:113407. PMC: 7434361. DOI: 10.1016/j.psychres.2020.113407. View

17.

Haydon K, Salvatore J . A Prospective Study of Mental Health, Well-Being, and Substance Use During the Initial COVID-19 Pandemic Surge. Clin Psychol Sci. 2022; 10(1):58-73. PMC: 8845503. DOI: 10.1177/21677026211013499. View

18.

Buysse D, Reynolds 3rd C, Monk T, BERMAN S, Kupfer D . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2):193-213. DOI: 10.1016/0165-1781(89)90047-4. View

19.

Xiong J, Lipsitz O, Nasri F, Lui L, Gill H, Phan L . Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020; 277:55-64. PMC: 7413844. DOI: 10.1016/j.jad.2020.08.001. View

20.

Zvolensky M, Garey L, Rogers A, Schmidt N, Vujanovic A, Storch E . Psychological, addictive, and health behavior implications of the COVID-19 pandemic. Behav Res Ther. 2020; 134:103715. PMC: 7451060. DOI: 10.1016/j.brat.2020.103715. View